Impact on Quality of Life by Moxibustion in Chemotherapy for Cancer
NCT ID: NCT02261571
Last Updated: 2014-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2014-10-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Herein, the investigators propose an open-label pilot study investigating the effectiveness of moxibustion stimulation at abdominal acupoint on quality of life in cancer patients under chemotherapy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Limiting Chemotherapy Side Effects by Using Moxa
NCT02781155
Personalized Electroacupuncture Treatment for Chemotherapy-induced Nausea and Vomiting in Breast Cancer (PET)
NCT05275569
Effects of Mobile Game on Life Quality of Cancer Patients
NCT03205969
Effect of Chan-Chuang Qigong With Breathing Meditation on Quality of Life in Patients With Breast Cancer
NCT05385146
Predisposing Factors Associated With Chemotherapy Toxicity in Elderly Cancer Patients
NCT02317757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Moxibustion
A series of moxibustion sessions within six weeks from baseline with adjuvant chemotherapy.
Moxibustion
In the moxibustion treatment group, 3 moxibustion, 3 acupoints(CV12, CV8, CV54) will be heated with indirected moxibustion.
The moxibustion will be removed when the patient feel hotness and require remove them
Waiting
Participants who will be allocated to waitlist will receive no moxibustion treatments throughout the 6 weeks while receiving adjuvant chemotherapy
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Moxibustion
In the moxibustion treatment group, 3 moxibustion, 3 acupoints(CV12, CV8, CV54) will be heated with indirected moxibustion.
The moxibustion will be removed when the patient feel hotness and require remove them
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Performance status of 0-2 on the European Cooperative Oncology Group (ECOG) performance scale.
* Patients on chemotherapy currently have plan to receive chemotherapy for more than 6 weeks.
* Follow-up possible during the clinical trial
* Informed signed consent
Exclusion Criteria
* Patients with diabetes that is not controlled (FBST \>180 or BST\>250)
* Patients with abdominal injury or severe ascites can't be received moxibustion therapy on abdomen.
* Hypersensitive section to moxibustion treatment
* Inability to comprehend or express oneself in the Korean language
* An Individual deemed to be ineligible by a physician
* Refusal to participate in this trial or to provide informed consent.
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Comprehensive and Integrative Medicine Institute of South Korea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hyun jung, Jung
assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Deagu Hanny University Medical center
Deagu, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hyun Jung Jung, KMD, Ph. D
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Lee MS, Kang JW, Ernst E. Does moxibustion work? An overview of systematic reviews. BMC Res Notes. 2010 Nov 5;3:284. doi: 10.1186/1756-0500-3-284.
Lee MS, Choi TY, Park JE, Lee SS, Ernst E. Moxibustion for cancer care: a systematic review and meta-analysis. BMC Cancer. 2010 Apr 7;10:130. doi: 10.1186/1471-2407-10-130.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIMI-14-01-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.